The cost of treatment with redecision COVID-19 will be 2340 dollars

Gilead announced the pricing of ramdevpir: in the US the treatment of one patient with coronavirus new drug will cost 2340 dollars. One vial of the drug in the United States and for governments in developing countries will cost $ 390, while American insurance companies have to pay 520 dollars for a bottle (and 3120 dollars for a five-day course), writes Reuters.

Antiretroviral ramdevpir was the first drug that demonstrated in clinical studies its effectiveness in the treatment of coronavirus infection. Gilead has already signed an agreement with the U.S. government on the use of ramdevpir therapy COVID-19, the agreement will be valid until the end of September 2020.

Currently, medicine is available in form for intravenous injection, however, in August 2020 Gilead intends to begin clinical trials more easy to use form LS – inhalation.

Leave a Reply

Your email address will not be published. Required fields are marked *


The largest pharmaceutical companies refuse advertising in Facebook

A number of international pharmaceutical manufacturers joined the campaign Stop Hate for Profit, in which brands refuse advertising in Facebook. Pfizer, Novartis and AbbVie announced the termination of the advertising placements on the social network in July, reports FiercePharma. The purpose of the traffic Stop Hate for Profit is putting pressure on the social network […]

In Russia confirmed 6 718 new cases COVID-19

A day in Russia revealed 6 718 new cases of coronavirus infection in 84 regions. In 32,5% of patients there are no clinical manifestations of the disease. The day passed away 176 people, was fully recovered 8 915 patients. In Moscow confirmed 659 new cases COVID-19. This is 89% less than 2 months ago, may […]